Institutional Ownership
Centessa Pharmaceuticals PLC
CUSIP 152309100SPONSORED ADSCNTAQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
12.2%
Max % of class reported
Institutional Holders
160
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Avoro Capital Advisors LLC | 13G/A | 10.0% | 14.56M | SEC |
| 2 | Feb 6, 2026 | Fmr LLC | 13G/A | 12.2% | 11.00M | SEC |
| 3 | Feb 5, 2026 | Fmr LLC | 13G/A | 9.9% | 8.89M | SEC |
| 4 | Nov 28, 2025 | General Atlantic Cooperatief U.A. | 13D/A | 5.0% | — | SEC |
| 5 | Nov 17, 2025 | General Atlantic Cooperatief U.A. | 13D/A | 6.6% | — | SEC |
| 6 | Nov 14, 2025 | Avoro Capital Advisors LLC | 13G | 8.1% | 10.81M | SEC |
| 7 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G/A | 7.5% | 10.04M | SEC |
| 8 | Nov 5, 2025 | Fmr LLC | 13G | 7.0% | 6.28M | SEC |
| 9 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 6.3% | 8.40M | SEC |
| 10 | May 12, 2025 | Adage Capital Management, L.P. | 13G | 5.2% | 6.95M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Centessa Pharmaceuticals PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Medicxi Ventures Management (Jersey) Ltd | 19.96M | $792.94M |
| 2 | Avoro Capital Advisors LLC | 11.43M | $454.02M |
| 3 | Index Venture Life Associates Vi Ltd | 9.96M | $395.68M |
| 4 | Adage Capital Partners Gp, L.L.C. | 8.93M | $354.50M |
| 5 | Pentwater Capital Management LP | 8.17M | $324.51M |
| 6 | Fmr LLC | 6.85M | $272.16M |
| 7 | Ecor1 Capital, LLC | 6.00M | $238.32M |
| 8 | Perceptive Advisors LLC | 5.26M | $208.88M |
| 9 | Capital World Investors | 4.83M | $191.95M |
| 10 | Farallon Capital Management LLC | 4.81M | $191.01M |